About this Site

If you or someone you love has been diagnosed with prostate cancer, you’ve probably already visited some websites that provide useful information about what prostate cancer is, how it’s diagnosed, and the many alternatives that are available for treating (or not treating) it.  The ones I consider to be most important are listed at the Resources page at this site.

So, what makes this web site different?

My 360-degree focus at this site and in my blog posts is on the non-clinical issues and controversies surrounding cancer in general and prostate cancer in particular.  Cancer’s emotional, psychological, economic, and spiritual impacts on men and their loved ones are just as crucial as its medical aspects.

As far as prostate cancer is concerned, the National Cancer Institute (NCI) estimates that in 2015 about 220,000 men will be diagnosed with this cancer.  Most prostate cancer is diagnosed when men are between 65 and 70 years old. “Leading edge” boomers born in 1946 and 1947 are now 68–and there are millions more men behind us..   So, in the next few yofears, the great majority  men diagnosed with PCa (the abbreviation for prostate cancer) will be boomers.

So, a central question is how does cancer—prostate cancer in particular—affect us boomers?  Conversely, how are we boomers likely to impact the landscape of cancer?  How will we shape the diagnoses, treatments, economics, policy, and culture of cancer?  And how will we boomers impact men’s health in general?

We’ll explore these issues from two perspectives:

The Personal: From my perspective as a “leading edge” boomer born in late 1946, I’ll reflect on the physical, social, emotional, and spiritual aspects being diagnosed, treated, and living with high-risk, advanced prostate cancer.

The Societal: I’ll be looking at the impact of boomers and their cancers are having, and are likely to have, on attitudes about men’s health and American society at large: its attitudes, mores, economics, advocacy, politics, and policies.

Advocacy: Everyone knows what “pink October” is all about. But far fewer know that blue is to prostate cancer as pink is to breast cancer. How do we raise awareness that one in six men will face a prostate cancer diagnosis in his lifetime?

I hope you find your visit at this site worthwhile, and that you’ll be a frequent participant in the dialogue as we delve into these important issues.

–Craig Pynn